Evidence map›Paper›PMID 26485349›Full record

ArticleMagnetic resonance in medicine2016

Characterizing blood-brain barrier perturbations after exposure to human triglyceride-rich lipoprotein lipolysis products using MRI in a rat model.

Kit Fai Ng, Steve Anderson, Patrice Mayo, Hnin Hnin Aung, Jeffrey H Walton, John C Rutledge

Open access · hybridAbstract read
In one paragraph

Article in Magnetic resonance in medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.8field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Lower serum triglyceride levels linked to more severe motor performance in Parkinson's disease.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2022
    Article
  5. Article
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Kit Fai NgSchool of Medicine, Division of Cardiovascular Medicine, University of California, Davis, California, USA.
Steve AndersonSchool of Medicine, Department of Physiology and Membrane Biology, University of California, Davis, California, USA.
Patrice MayoSchool of Medicine, Division of Cardiovascular Medicine, University of California, Davis, California, USA.
Hnin Hnin AungSchool of Medicine, Division of Cardiovascular Medicine, University of California, Davis, California, USA.
Jeffrey H WaltonNMR Facility and Biomedical Engineering Graduate Group, University of California, Davis, California, USA.
John C RutledgeSchool of Medicine, Division of Cardiovascular Medicine, University of California, Davis, California, USA. jcrutledge@ucdavis.edu.
University of California, Davis · US

Funding

Mouse Metabolic Phenotyping Center (MMPC) at UC DavisU2CDK092993 · NIDDK · UNIVERSITY OF CALIFORNIA AT DAVIS · PI LLOYD, KC KENT · 2016 to 2021
$5.9M
Mouse Metabolic Phenotyping Center (MMPC) at UC DavisU24DK092993 · NIDDK · UNIVERSITY OF CALIFORNIA AT DAVIS · PI LLOYD, KC KENT · 2011 to 2015
$4.1M
Brain Microvascular Determinants of Alzheimers DiseaseR01AG039094 · NIA · UNIVERSITY OF CALIFORNIA AT DAVIS · PI RUTLEDGE, JOHN CALVERT · 2010 to 2014
$2.1M
Role of lipid droplets in neurovascular inflammationR01AG045541 · NIA · UNIVERSITY OF CALIFORNIA AT DAVIS · PI RUTLEDGE, JOHN CALVERT, VILLABLANCA, AMPARO C · 2014 to 2018
$2.0M
NIA NIH HHS R01 AG039094NIA NIH HHS R01 AG045541NIDDK NIH HHS U24 DK092993NIDDK NIH HHS U2C DK092993
6 · The paper itself

Abstract

purposePrevious studies indicated hyperlipidemia may be a risk factor for Alzheimer's disease, but the contributions of postprandial triglyceride-rich lipoprotein (TGRL) are not known. In this study, changes in blood-brain barrier diffusional transport following exposure to human TGRL lipolysis products were studied using MRI in a rat model.

methodsMale Sprague-Dawley rats (∼180-250 g) received an i.v. injection of lipoprotein lipase (LpL)-hydrolyzed TGRL (n = 8, plasma concentration ≈ 150 mg human TGRL/dL). Controls received i.v. injection of either saline (n = 6) or LpL only (n = 6). The (1) H longitudinal relaxation rate R1  = 1/T1 was measured over 18 min using a rapid-acquired refocus-echo (RARE) sequence after each of three injections of the contrast agent Gd-DTPA. Patlak plots were generated for each pixel yielding blood-to-brain transfer coefficients, Ki , chosen for best fit to impermeable, uni-directional influx or bi-directional flux models using the F-test.

resultsAnalysis from a 2-mm slice, 2-mm rostral to the bregma showed a 275% increase of mean Ki during the first 20 min after infusion of human TGRL lipolysis product that differed significantly compared with saline and LpL controls. This difference disappeared by 40 min mark.

conclusionThese results suggest human TGRL lipolysis products can lead to a transient increase in rat BBB permeability. Magn Reson Med 76:1246-1251, 2016. © 2015 The Authors. Magnetic Resonance in Medicine published by Wiley Periodicals, Inc. on behalf of International Society for Magnetic Resonance in Medicine. This is an open access article under the terms of the Creative Commons Attribution NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.

Indexed as

AnimalsBlood-Brain BarrierInjections, IntravenousLipoproteinsMagnetic Resonance AngiographyMaleRatsRats, Sprague-DawleyTriglyceridesLipoproteinslipoprotein triglycerideTriglyceridesblood-brain barrierGd-DTPAhyperlipidemiapermeabilitytriglyceride-rich lipoprotein

Identifiers

PMID26485349
PMCPMC4838551
OpenAlexW2115487437

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.